Koers Biofil Chemicals and Pharmaceuticals Limited
Aandelen
BIOFILCHEM
INE829A01014
Farmaceutische producten
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
70,85 INR | -0,35% | -1,31% | +31,13% |
Omzet 2022 | 224 mln. 2,68 mln. 2,51 mln. | Omzet 2023 | 300 mln. 3,6 mln. 3,36 mln. | Marktkapitalisatie | 674 mln. 8,08 mln. 7,55 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | 6 mln. 71,92K 67,21K | Nettowinst (verlies) 2023 | 5 mln. 59,93K 56,01K | EV/omzet 2022 | 4,22 x |
Nettoschuld 2022 | 3,2 mln. 38,33K 35,82K | Nettoschuld 2023 | 4,88 mln. 58,46K 54,63K | EV/omzet 2023 | 2,26 x |
K/w-verhouding 2022 |
135
x | K/w-verhouding 2023 |
122
x | Werknemers | 47 |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 40,72% |
1 dag | -0,35% | ||
1 week | -1,31% | ||
Lopende maand | +17,38% | ||
1 maand | +3,99% | ||
3 maanden | +0,41% | ||
6 maanden | +48,88% | ||
Lopend jaar | +31,13% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Ketan Shah
CEO | Chief Executive Officer | 62 | 01-04-85 |
Ramesh S. Shah
CEO | Chief Executive Officer | 87 | 04-01-85 |
Director of Finance/CFO | 33 | 14-11-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Ramesh S. Shah
CEO | Chief Executive Officer | 87 | 04-01-85 |
Romil Shah
BRD | Director/Board Member | 39 | 30-07-05 |
Ketan Shah
ADM | Chief Administrative Officer | 62 | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
30-04-24 | 70,85 | -0,35% | 2 321 |
29-04-24 | 71,1 | +1,92% | 3 922 |
26-04-24 | 69,76 | -1,70% | 7 492 |
25-04-24 | 70,97 | -2,33% | 9 874 |
24-04-24 | 72,66 | +1,21% | 9 612 |
uitgestelde koers Bombay S.E., 30 april 2024 om 12:00 uur
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
+31,13% | 13,87 mln. | |
+19,27% | 43,75 mld. | |
+27,47% | 22,06 mld. | |
+15,37% | 14,46 mld. | |
+12,33% | 13,62 mld. | |
+38,36% | 11,61 mld. | |
-9,54% | 6,9 mld. | |
-0,05% | 6,79 mld. | |
-8,87% | 5,73 mld. | |
+9,64% | 5,32 mld. |